The systemic inflammatory response syndrome
- PMID: 15212339
- DOI: 10.1016/j.bpa.2003.12.005
The systemic inflammatory response syndrome
Abstract
Sepsis and septic shock are the leading causes of death in intensive care units in developed countries despite recent advances in critical care medicine. Sepsis is the systemic inflammatory response to infection frequently associated with hypoperfusion followed by tissue injury and organ failure. The activation of monocytes/macrophages and neutrophils, with the consecutive release of pro-inflammatory mediators and activation of the coagulation cascade, seems to play a key role in the pathogenesis of sepsis. Elimination of the septic focus, anti-microbial therapy and supportive treatment are the cornerstones of sepsis therapy. In addition, the application of small doses hydrocortisone to patients with refractory septic shock and the treatment of patients with septic multiple organ failure with activated protein C are two adjunctive therapeutic strategies. Promising new experimental treatment options are interference with MIF, HMGB1, C5a or TREM-1 signal transduction pathways and an inhibition of apoptosis, which may further improve the prognosis of septic patients in the future.
Similar articles
-
[Clinical management of patients with sepsis].Anaesthesist. 2003 Jan;52(1):3-22. doi: 10.1007/s00101-002-0436-0. Anaesthesist. 2003. PMID: 12577161 Review. German.
-
[Physiopathology of severe sepsis].Presse Med. 2004 Feb 28;33(4):256-61; discussion 269. doi: 10.1016/s0755-4982(04)98551-x. Presse Med. 2004. PMID: 15029017 Review. French.
-
[Toll-like receptors and their role in regulation of the inflammatory response in sepsis].Anestezjol Intens Ter. 2008 Oct-Dec;40(4):253-59. Anestezjol Intens Ter. 2008. PMID: 19517667 Review. Polish.
-
[Diagnosis of sepsis, severe sepsis and septic shock].Presse Med. 2004 Feb 28;33(4):262-4; discussion 269. doi: 10.1016/s0755-4982(04)98552-1. Presse Med. 2004. PMID: 15029018 French.
-
New insight into the pathogenesis of sepsis and the sepsis syndrome.Surgery. 2005 Apr;137(4):393-5. doi: 10.1016/j.surg.2004.08.001. Surgery. 2005. PMID: 15800483 Review. No abstract available.
Cited by
-
Triggering receptor expressed on myeloid cells-1 in sepsis, and current insights into clinical studies.Crit Care. 2024 Jan 9;28(1):17. doi: 10.1186/s13054-024-04798-2. Crit Care. 2024. PMID: 38191420 Free PMC article. Review.
-
Understanding the Pathophysiological and Clinical Changes in Lung Injury Models.Am J Respir Crit Care Med. 2023 Sep 1;208(5):632-633. doi: 10.1164/rccm.202305-0826LE. Am J Respir Crit Care Med. 2023. PMID: 37315324 Free PMC article. No abstract available.
-
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease.Int J Mol Sci. 2023 Mar 12;24(6):5420. doi: 10.3390/ijms24065420. Int J Mol Sci. 2023. PMID: 36982492 Free PMC article. Review.
-
TREM-1 Modulation Strategies for Sepsis.Front Immunol. 2022 Jun 15;13:907387. doi: 10.3389/fimmu.2022.907387. eCollection 2022. Front Immunol. 2022. PMID: 35784361 Free PMC article. Review.
-
MiR-501-5p alleviates cardiac dysfunction in septic patients through targeting NR4A3 to prevent its binding with Bcl-2.Cell Cycle. 2022 May;21(9):961-971. doi: 10.1080/15384101.2022.2035618. Epub 2022 Mar 1. Cell Cycle. 2022. PMID: 35230891 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous